Sanford B. Krantz
#152,380
Most Influential Person Now
Sanford B. Krantz's AcademicInfluence.com Rankings
Sanford B. Krantzphilosophy Degrees
Philosophy
#8477
World Rank
#11867
Historical Rank
Logic
#5505
World Rank
#6910
Historical Rank
Sanford B. Krantzbiology Degrees
Biology
#11481
World Rank
#14881
Historical Rank
Molecular Biology
#1765
World Rank
#1794
Historical Rank
Download Badge
Philosophy Biology
Sanford B. Krantz's Degrees
- PhD Molecular Biology Stanford University
- Doctorate Medicine Stanford University
Why Is Sanford B. Krantz Influential?
(Suggest an Edit or Addition)Sanford B. Krantz's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Identification of an Acquired JAK2 Mutation in Polycythemia Vera* (2005) (666)
- Progress in understanding the pathogenesis of the anemia of chronic disease. (1992) (555)
- Erythroid response to treatment with G‐CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: proposal for a predictive model (1997) (296)
- Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritis. (1990) (231)
- Purification of human erythroid colony-forming units and demonstration of specific binding of erythropoietin. (1987) (223)
- Blunted erythropoietin response to anaemia in rheumatoid arthritis (1987) (213)
- Human colony-forming units-erythroid do not require accessory cells, but do require direct interaction with insulin-like growth factor I and/or insulin for erythroid development. (1989) (210)
- Maintenance treatment of the anemia of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor and erythropoietin: evidence for in vivo synergy. (1996) (207)
- Binding and receptor-mediated endocytosis of erythropoietin in Friend virus-infected erythroid cells. (1987) (207)
- Interferon γ Induces Upregulation and Activation of Caspases 1, 3, and 8 to Produce Apoptosis in Human Erythroid Progenitor Cells (1999) (192)
- Distinct roles of erythropoietin, insulin-like growth factor I, and stem cell factor in the development of erythroid progenitor cells. (1994) (186)
- The Anemia of Primary Autonomic Failure and its Reversal with Recombinant Erythropoietin (1994) (185)
- THE EFFECT OF ERYTHROPOIETIN UPON HEME SYNTHESIS BY MARROW CELLS IN VITRO. (1963) (177)
- Studies on red cell aplasia. I. Demonstration of a plasma inhibitor to heme synthesis and an antibody to erythroblast nuclei. (1967) (174)
- Fas ligand is present in human erythroid colony-forming cells and interacts with Fas induced by interferon gamma to produce erythroid cell apoptosis. (1998) (167)
- Anemia of the critically ill: "acute" anemia of chronic disease. (2000) (164)
- Inhibition of human erythroid colony-forming units by gamma interferon can be corrected by recombinant human erythropoietin. (1991) (159)
- Treatment of the anemia of myelodysplastic syndromes using recombinant human granulocyte colony-stimulating factor in combination with erythropoietin. (1993) (158)
- Pathogenesis and Treatment of the Anemia of Chronic Disease (1994) (153)
- Inhibition of human erythroid colony-forming units by tumor necrosis factor requires beta interferon. (1993) (150)
- Pharmacologic doses of recombinant human erythropoietin in the treatment of myelodysplastic syndromes. (1991) (149)
- Differentiation and erythropoietin receptor gene expression in human erythroid progenitor cells. (1992) (149)
- Inhibition of human erythroid colony‐forming units by interleukin‐1 is mediated by gamma interferon (1992) (148)
- Human burst-forming units-erythroid need direct interaction with stem cell factor for further development. (1991) (144)
- Stem cell factor retards differentiation of normal human erythroid progenitor cells while stimulating proliferation. (1995) (144)
- Erythropoietin and the regulation of Erythropoiesis (1970) (142)
- JAK2(V617F): Prevalence in a large Chinese hospital population. (2007) (141)
- Erythropoietin and the control of red cell production. (1978) (139)
- Studies on red cell aplasia. V. Presence of erythroblast cytotoxicity in G-globulin fraction of plasma. (1973) (136)
- Treatment of the anemia of rheumatoid arthritis with recombinant human erythropoietin: clinical and in vitro studies. (1989) (134)
- Double-blind, placebo-controlled study of the therapeutic use of recombinant human erythropoietin for anemia associated with chronic renal failure in predialysis patients (1991) (130)
- Receptors for erythropoietin in mouse and human erythroid cells and placenta. (1989) (121)
- The pathogenesis of anemia in rheumatoid arthritis: a clinical and laboratory analysis. (1990) (121)
- Effects of recombinant erythropoietin on the concentration and cycling status of human marrow hematopoietic progenitor cells in vivo. (1988) (113)
- Pure red cell aplasia. (1974) (113)
- Studies on red cell aplasia. II. Report of a second patient with an antibody to erythroblast nuclei and a remission after immunosuppressive therapy. (1969) (112)
- Studies on pure red cell aplasia. XI. Results of immunosuppressive treatment of 37 patients. (1984) (109)
- Specific binding of erythropoietin to spleen cells infected with the anemia strain of Friend virus. (1984) (106)
- On the mechanism of erythropoietin-induced differentiation. II. T he effect on RNA synthesis. (1965) (101)
- Synergistic activation of MAP kinase (ERK1/2) by erythropoietin and stem cell factor is essential for expanded erythropoiesis. (1998) (100)
- Polycythemia vera. II: Hypersensitivity of bone marrow erythroid, granulocyte-macrophage, and megakaryocyte progenitor cells to interleukin-3 and granulocyte-macrophage colony-stimulating factor (1992) (95)
- Polycythemia vera blood burst-forming units-erythroid are hypersensitive to interleukin-3. (1991) (94)
- Treatment of the Anemia of Predialysis Patients with Recombinant Human Erythropoietin: A Randomized, Placebo‐Controlled Trial (1988) (90)
- Interferon gamma induces upregulation and activation of caspases 1, 3, and 8 to produce apoptosis in human erythroid progenitor cells. (1999) (88)
- Identification of the receptor for erythropoietin by cross-linking to Friend virus-infected erythroid cells. (1987) (88)
- Inhibition of human colony-forming-unit erythroid by tumor necrosis factor requires accessory cells. (1990) (82)
- Transferrin receptor number, synthesis, and endocytosis during erythropoietin-induced maturation of Friend virus-infected erythroid cells. (1986) (78)
- Interferon γ Downregulates Stem Cell Factor and Erythropoietin Receptors But Not Insulin-Like Growth Factor-I Receptors in Human Erythroid Colony-Forming Cells (1997) (77)
- Mode of action of the IgG inhibitor of erythropoiesis in transient erythroblastopenia of children. (1982) (77)
- Upper airway obstruction as a complication of oral anticoagulation therapy. Report of three cases. (1979) (71)
- Erythroid bursts produced by Friend leukaemia virus in vitro (1978) (68)
- Diagnosis and treatment of pure red cell aplasia. (1976) (67)
- Studies on extrarenal erythropoietin. (1969) (65)
- Erythropoietin stimulates 45Ca2+ uptake in Friend virus-infected erythroid cells. (1984) (63)
- Polycythemia vera. II. Hypersensitivity of bone marrow erythroid, granulocyte-macrophage, and megakaryocyte progenitor cells to interleukin-3 and granulocyte-macrophage colony-stimulating factor. (1992) (59)
- Erythropoietin: biology and clinical use. (1989) (59)
- Increased sensitivity to complement of erythroid and myeloid progenitors in paroxysmal nocturnal hemoglobinuria. (1983) (58)
- Increased erythropoiesis in polycythemia vera is associated with increased erythroid progenitor proliferation and increased phosphorylation of Akt/PKB. (2005) (57)
- Changes in cytoskeletal proteins and their mRNAs during maturation of human erythroid progenitor cells (1994) (57)
- Synergistic activation of MAP kinase (ERK1/2) by erythropoietin and stem cell factor is essential for expanded erythropoiesis (1998) (55)
- Inhibition of human erythroid colony-forming units by interferons alpha and beta: differing mechanisms despite shared receptor. (1996) (54)
- Malignant lymphomas of follicular center cell origin in man. III. Prognostic Features (1979) (53)
- Inhibition of murine erythroid colony formation in vitro by interferon gamma and correction by interferon receptor immunoadhesin. (1994) (53)
- Polycythemia vera. V. Enhanced proliferation and phosphorylation due to vanadate are diminished in polycythemia vera erythroid progenitor cells: a possible defect of phosphatase activity in polycythemia vera. (1997) (52)
- Successful Immunosuppressive Treatment of Erythroid Aplasia Appearing after Thymectomy (1970) (48)
- Distinct roles of JNKs/p38 MAP kinase and ERKs in apoptosis and survival of HCD-57 cells induced by withdrawal or addition of erythropoietin. (1999) (47)
- Studies on red cell aplasia. 3. Treatment with horse antihuman thymocyte gamma globulin. (1972) (47)
- PTP-MEG2 is activated in polycythemia vera erythroid progenitor cells and is required for growth and expansion of erythroid cells. (2003) (46)
- Erythropoietin receptors in polycythemia vera. (1989) (46)
- Identification of increased protein tyrosine phosphatase activity in polycythemia vera erythroid progenitor cells. (1997) (45)
- Rheumatoid arthritis and pure red cell aplasia. (1984) (45)
- Erythropoietin Response to Anemia as a Function of Age (1991) (43)
- Interferon gamma downregulates stem cell factor and erythropoietin receptors but not insulin-like growth factor-I receptors in human erythroid colony-forming cells. (1997) (43)
- Target cells for friend virus-induced erythroid bursts in vitro (1979) (43)
- Chronic mucocutaneous candidiasis with macrophage dysfunction, a plasma inhibitor, and co-existent aplastic anemia. (1975) (43)
- Abundance and stability of erythropoietin receptor mRNA in mouse erythroid progenitor cells. (1991) (42)
- Cimetidine-induced neutropenia: a possible dose-related phenomenon. (1979) (42)
- Treatment of refractory pure red cell aplasia with cyclosporine A: disappearance of IgG inhibitor associated with clinical response (1991) (41)
- Studies on pure red cell aplasia. VI. Development of two-stage erythroblast cytotoxicity method and role of complement. (1973) (40)
- Diphenylhydantoin-induced pure red cell aplasia. (1985) (39)
- Specific differentiation events induced by erythropoietin in cells infected in vitro with the anemia strain of Friend virus. (1982) (36)
- Interferon gamma delays apoptosis of mature erythroid progenitor cells in the absence of erythropoietin. (2000) (35)
- Specific Interaction of Protein Tyrosine Phosphatase-MEG2 with Phosphatidylserine* (2003) (35)
- Response of polycythemia vera marrow to erythropoietin in vitro. (1968) (35)
- Acquired immune hemolytic anemia associated with IgA erythrocyte coating: investigation of hemolytic mechanisms. (1984) (35)
- Studies on erythropoiesis. XIV. The relationship of humoral stimulation to iron absorption. (1959) (33)
- The effect of erythropoietin on human bone marrow cells in vitro. (1965) (32)
- Letter: Translocation of the Philadelphia chromosome onto the 17 short arm in chronic myeloid leukemia: a second example. (1975) (32)
- On the mechanism of erythropoietin-induced differentiation. IV. Some characteristics of erythropoietin action on hemoglobin synthesis in marrow cell culture. (1965) (32)
- Increased expression of the INK4a/ARF locus in polycythemia vera. (2001) (31)
- Erythropoietin and the anaemia of chronic disease. (1995) (31)
- Erythroid-specific processing of human beta spectrin I pre-mRNA. (1994) (29)
- PURE RED CELL APLASIA (1973) (29)
- Stem cell factor increases the expression of FLIP that inhibits IFNgamma -induced apoptosis in human erythroid progenitor cells. (2003) (28)
- Role of tyrosine kinases and phosphatases in polycythemia vera. (2005) (27)
- Identification of an Acquired JAK 2 Mutation in Polycythemia (2005) (27)
- The anemia of microgravity and recumbency: role of sympathetic neural control of erythropoietin production. (1994) (25)
- Use of recombinant human erythropoietin to enhance autologous blood donation in a patient with multiple red cell allo-antibodies and the anemia of chronic disease. (1991) (24)
- Purification of human marrow progenitor cells and demonstration of the direct action of macrophage colony-stimulating factor on colony-forming unit-macrophage. (1991) (23)
- Isolation of erythropoietin-sensitive cells from Friend virus-infected marrow cultures: characteristics of the erythropoietin response. (1983) (22)
- In vitro expression of erythroid differentiation induced by Friend polycythaemia virus (1975) (21)
- Mature erythroid burst-forming units are target cells for Friend virus-induced erythroid bursts. (1981) (20)
- Re-treatment of aplastic anemia with antithymocyte globulin or antilymphocyte serum. (1988) (19)
- Specific binding of interferon-gamma to high affinity receptors on human erythroid colony-forming cells. (1997) (18)
- Lack of effect of erythropoietin on cyclic adenosine-3',5'-monophosphate levels in rat fetal liver cells. (1974) (18)
- Chromosome banding patterns of 49 cases of chronic myelocytic leukemia. (1977) (17)
- Dynamic changes in the locus control region of erythroid progenitor cells demonstrated by polymerase chain reaction. (1996) (16)
- Photoaffinity labeling of the erythropoietin receptor and its identification in a ligand-free form. (1991) (16)
- Stem cell factor can overcome inhibition of highly purified human burst‐forming units‐erythroid by interferon γ (1995) (15)
- Variable differentiation patterns of acute myelogenous leukaemia blasts in liquid suspension cultures (1987) (14)
- Pure red cell aplasia associated with administration of sustained-release procainamide. (1987) (13)
- In vitro behavior of stem cells. (1968) (13)
- The role of erythropoietin in erythroid cell differentiation. (1988) (12)
- The Effect of Cyclic AMP on Heme Synthesis by Rat Bone Marrow Cells in Vitro 1 (1972) (11)
- Chromosome band analysis in 19 cases of chronic myeloid leukemia: 9 chronic, 10 blastic, two with Ph1 (22q-) translocation on 17 short arm. (1975) (11)
- Response of Erythroid Day 3 Burst-Forming Units to Endotoxin and Erythropoietin (1979) (10)
- Erythropoietin and erythroid differentiation. (1984) (9)
- Beneficial effect of hepatitis in leukemic reticuloendotheliosis. (1981) (9)
- Case report: granulocyte colony-stimulating factor overcomes severe neutropenia of large granular lymphocytosis. (1992) (9)
- APPLICATION OF THE IN VITRO ERYTHROPOIETIN SYSTEM TO THE STUDY OF HUMAN BONE MARROW DISEASE: POLYCYTHEMIA VERA (1968) (8)
- Serum Erythropoietin in Healthy Older Persons (1989) (8)
- OSTEOMYELITIS AND LYMPHOMA (1979) (8)
- The Fv-2 gene controls induction of erythroid burst formation by Friend virus infection in vitro: studies of growth regulators and viral replication. (1985) (8)
- Vanadate mimics the effect of stem cell factor on highly purified human erythroid burst-forming units in vitro, but not the effect of erythropoietin. (1992) (8)
- Editorial: Recent contributions to the mechanism of action and clinical relevance of erythropoietin. (1973) (7)
- Erythropoietin: regulation of erythropoiesis and clinical use. (1990) (7)
- In vitro transformation of mouse hematopoietic cells by the spleen focus-forming virus. (1980) (7)
- Rapid in vivo assay for Friend polycythemia virus. (1974) (7)
- Detection of cytotoxic antibody to erythroblasts. (1977) (6)
- Splenic erythroid response to friend polycythemia virus: time course in vitro after infection in vivo. (1977) (6)
- Treatment of Aplastic Anemia With an Investigational Antilymphocyte Serum Prepared in Rabbits (1994) (6)
- Bone-marrow imaging in pure red blood cell aplasia. (1976) (6)
- Annotation: pure red cell aplasia. (1973) (6)
- Quantitation of insulin-like growth factor-I binding to highly purified human erythroid colony-forming units. (1991) (5)
- Primary Refractory Anemia: Clinical and Laboratory Study of Erythropoiesis in 16 Patients (1985) (5)
- Prediction of response to G-CSF and epo treatment for the anaemia of myelodysplastic syndromes (MDS) (1994) (5)
- Specific binding of erythropoietin to human erythroid colony-forming cells. (1987) (5)
- JAK2V617F : prevalence in a large Chinese hospital population. Commentary (2007) (5)
- Current status of erythropoietin. (1970) (5)
- An In Vitro System for Erythroid Transformation by Friend Leukemia Virus (1979) (5)
- Special Feature: New Therapies for Aplastic Anemia (1986) (5)
- New therapies for aplastic anemia. (1986) (5)
- Use of Purified Erythropoietin Responsive Cells Produced by the Anemia Strain of Friend Virus to Study the Action of Erythropoietin (1987) (4)
- Production of spleen focus-forming virus and murine leukemia virus by early erythroblasts after Friend virus infection. (1980) (4)
- Purification of erythroid progenitor cells and characterization of erythropoietin receptors. (1988) (4)
- Evidence that endotoxin is the cyclic 3':5'-GMP--promoting factor in erythropoietin preparations. (1979) (4)
- Effects of sulfhydryl compounds on Friend virus-infected spleen cells in vitro. (1979) (4)
- SUMMARY OF CONFERENCE ON ERYTHROPOIETIN (1968) (3)
- Friend virus production and heme synthesis in primary mouse spleen cell cultures. (1979) (3)
- The effect of Friend polycythemia virus on splenic uptake of 59 Fe in fasted mice. (1973) (3)
- Cytotoxicity for erythroblasts in horse antihuman thymocyte -globulin. (1973) (3)
- In human immature BFU-E tumor necrosis factor-alpha not only downregulates CDK6 but also directly produces apoptosis which is prevented by stem cell factor. (2004) (3)
- Paroxysmal nocturnal hemoglobinuria and pure red cell aplasia. Two rare anemias with immunologic implications. (1974) (3)
- Growth of highly purified human CFU-E in serum-free medium. (1990) (3)
- Increased sensitivity of polycythemia vera blood burst-forming units-erythroid to interleukin 3. (1990) (3)
- Erythropoietin: receptors and clinical use in rheumatoid arthritis. (1990) (2)
- Effect of erythropoietin preparations on cyclic AMP and cyclic GMP levels in rat fetal liver cell cultures. (1977) (2)
- Granulocyte colony stimulating factor plus erythropoietin for the maintenance treatment of the anemia of myelodysplastic syndromes (1994) (2)
- Gamma heavy chain disease--presenting as pancytopenia and splenomegaly. (1977) (2)
- Combined effect of friend polycythemia virus and erythropoietin on erythroid burst formation in vitro. (1980) (2)
- Purification and Culture of Erythroid Progenitor Cells (2002) (1)
- Studies on Pure Red Cell Aplasia (2005) (1)
- Haemoglobin Vanderbilt (alpha2beta289Ser leads to Arg): a new haemoglobin with high oxygen affinity and compensatory erythrocytosis. (1978) (1)
- Effects of ethanol on cultured human megakaryocytic progenitors. (1986) (1)
- Diphenyihydantoin-Induced Pure Red Cell Aplasia (1985) (1)
- Antibody-dependent cellular cytotoxicity to allogeneic but not autologous erythroblasts in vitro. (1982) (1)
- Antibody-dependent cellular cytotoxicity to allogeneic but not autologous erythroblastsin vitro (1982) (1)
- Quantitation of Friend spleen focus-forming virus by a nine-day 59Fe assay (1976) (0)
- STUDIES ON THE EFFECTS OF ERYTHROPOIETIN UPON MARROW CELLS IN VITRO. (1964) (0)
- Southern society for clinical investigation founders medal recipient's address. (1998) (0)
- The Effect of Ervthronoietin J I upon Heme Synthesis by Marrow Cells in Vitro (2003) (0)
- Binding studies on the erythropoietin receptor. (1991) (0)
- erythroid progenitor cells Abundance and stability of erythropoietin receptor mRNA in mouse (2011) (0)
- DIFFERENTIATION OF LEUKAEMIC MYELOBLASTS (1987) (0)
- treatment of myelodysplastic syndromes (see comments) Pharmacologic doses of recombinant human erythropoietin in the (2011) (0)
- A rapid in vivo assay for the friend polycythemia virus. Abstr. (1973) (0)
- The effect of cyclic AMP on heme synthesis by rat bone marrow cells. (1972) (0)
- status of human marrow hematopoietic progenitor cells in vivo Effects of recombinant erythropoietin on the concentration and cycling (2011) (0)
- Embryonic and Fetal Erythropoiesis (2019) (0)
- combination with erythropoietin (see comments) recombinant human granulocyte colony-stimulating factor in Treatment of the anemia of myelodysplastic syndromes using (2011) (0)
- Rapid Publication Erythropoietin Receptors in Polycythemia Vera (0)
- Erratum: Distinct roles of JNKS/p38 MAP kinase and ERKs in apoptosis and survival of HCD-57 cells induced by withdrawal or addition of erythropoietin (Blood (December 15, 1999) 94 (4067-4076)) (2001) (0)
- Thymoma and red-cell aplasia. (1973) (0)
- Thymocyte Gamma Globulin Studies on Red Cell Aplasia. III. Treatment With Horse Antihuman (2011) (0)
- erythropoietin: evidence for in vivo synergy with recombinant human granulocyte colony-stimulating factor and Maintenance treatment of the anemia of myelodysplastic syndromes (2011) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Sanford B. Krantz?
Sanford B. Krantz is affiliated with the following schools:
